On June 5, 2023, Telesis Bio, Inc. closed the transaction.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.555 USD | +1.00% | +7.95% | -36.65% |
May. 09 | Earnings Flash (TBIO) TELESIS BIO Reports Q1 Revenue $3.4M | MT |
May. 09 | Telesis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.65% | 7.54M | |
+11.26% | 227B | |
+15.25% | 198B | |
+18.09% | 142B | |
+31.31% | 111B | |
+1.56% | 64.16B | |
+18.23% | 54.1B | |
+5.12% | 51.41B | |
+10.62% | 45.32B | |
+5.04% | 37.32B |
- Stock Market
- Equities
- TBIO Stock
- News Telesis Bio, Inc.
- Telesis Bio, Inc. announced that it has received $28 million in funding from Novalis Capital Partners LLC, Northpond Ventures, LLC, BroadOak Capital Partners LLC, Investment Arm and another investor